Why Alignment Healthcare, Inc.’s (ALHC) Stock Is Up 5.68%
As of Friday, August 14, Alignment Healthcare, Inc.’s ALHC share price has surged by 5.68%, which has investors questioning if this is right time to sell.Cynthia McLaughlin
Stock Evaluator: Alignment Healthcare, Inc. (ALHC)
Alignment Healthcare, Inc. ALHC
$12.78
-0.45
-3.40%
August 19, 2026 4:00:00 PM
EST
Volume: 3,989,490
After Hours: $120.37
0.15
|
0.12%
November 10, 2021 7:59 PM
EST
Volume: 72,713
USD
NASD | DELAYED PRICE
| SECTOR | INDUSTRY |
| Health Care | Health Care Providers & Services |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Alignment Healthcare, Inc. operates a consumer-centric healthcare platform for seniors in the United States. It delivers customized healthcare experience to meet the needs of seniors through its Medicare Advantage plans. Alignment Healthcare, Inc. was founded in 2013 and is based in Orange, California.
Commentary & Analysis
Why Alignment Healthcare, Inc.’s (ALHC) Stock Is Up 6.73%
As of Friday, August 07, Alignment Healthcare, Inc.’s ALHC share price has surged by 6.73%, which has investors questioning if this is right time to sell.Michael Rose
Why Alignment Healthcare, Inc.’s (ALHC) Stock Is Down 5.05%
As of Tuesday, August 04, Alignment Healthcare, Inc.’s ALHC share price has dipped by 5.05%, which has investors questioning if this is right time to buy.Jenna Brashear
Which Is a Better Investment, Alignment Healthcare, Inc. or NeoGenomics, Inc. Stock?
Learn more about whether Alignment Healthcare, Inc. or NeoGenomics, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.Michael Rose
Why Alignment Healthcare, Inc.’s (ALHC) Stock Is Down 22.57%
As of Friday, July 31, Alignment Healthcare, Inc.’s ALHC share price has dipped by 22.57%, which has investors questioning if this is right time to buy.Michael Rose
Financial Summary
| Share Statistics | ALHC | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $2,682.1 | $1,982.5 | 58% |
|
| Shares Out (Mil) | 215.0 | 77.7 | 78% |
|
| Institutional Ownership | 97.3% | 86.1% | 73% |
|
| Float (Mil) | 187.8 | 52.1 | 73% |
|
| Beta | 1.13 | 0.75 | 68% |
|
| Avg Daily Volume (000s) | 4,694 | 637 | 92% |
|
| Price Change (52-week) |
(13.2%) | 79.7% | 34% |
|
| Growth | ALHC | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 32.7% | 10.9% | 91% |
|
| Net Income (5yr) | 50.2% | (1.6%) | 94% |
|
| EPS (5yr) | 51.6% | 0.3% | 93 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | (2.1%) | (17.9%) | 63% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 4 | 4 | 4 | |
| Current EPS | $0.060 | $0.495 | $0.753 | |
| Month Ago EPS | $0.135 | $0.475 | $0.723 | |
| # Rev Up | 0 | 0 | 0 | |
| # Rev Down | 0 | 1 | 0 | |
| Three Months Ago EPS | $0.135 | $0.475 | $0.723 | |
| Year/Year Chg | (64.7%) | (12,475%) | (28,425%) | |
| Financials | ALHC | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $4,577 | $1,504 | 73% |
|
| Net Income (TTM) (Mil) | $41 | $28 | 53% |
|
| EPS (TTM) | $0.200 | $0.200 | 47% |
|
| Operating Cash Flow (TTM) (Mil) | $206 | $162 | 59% |
|
| Net Cash Flow (TTM) (Mil) | $223 | $9 | 85% |
|
| Long-Term Debt (Q1) (Mil) | $331 | $338 | 54% |
|
| Enterprise Value (Q1) (Mil) | $2,475 | $2,416 | 52% |
|
| Valuation | ALHC | Industry Median |
Percentile (All Stocks) |
|
| P/B | 10.10 | 2.79 | 90% |
|
| P/E | 65.3 | 25.8 | 89% |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | 1.3 | 1.2 | 53% |
|
| Ratios | ALHC | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 12.5% | 27.8% | 12% |
|
| Net Margin | 0.9% | 1.2% | 34% |
|
| ROA | 3.6% | 2.2% | 65% |
|
| ROE | 20.0% | 7.2% | 79% |
|
| Liabilities to Assets | 79.3% | 58.6% | 74% |
|
| F-Score | 8 | 5 | 93% |
|
Alignment Healthcare, Inc. did not pass any screens on 8/20/2026.
